• Vold, Steven. “Study: Lower IOP, medication burden in OAG patients“, Ophthalmology Times, July 5 2021.

• Hirneiß, Christoph W. “Suprachoroidale Implantate: Aus der Sackgasse auf die Überholspur?” (German), Ophthalmo Chirurgie 33:163-168, May 2021.

• García Feijóo, Julián. “Drainage device offers IOP lowering capabilities at 1 year“, Ophthalmology Times, March 15 2021.

• Fea, A. “A new route to reducing IOP“, Ophthalmology Times Europe, January 23 2021.

• Perzia B, Vold S.D. “Suprachoroidal Devices in Glaucoma Therapy“, Glaucoma Physician, December 1 2020.

• Denis P, Hirneiß C, Reddy KP, Kamarthy A, Calvo E, Hussain Z, Ahmed IIK. “Two-year outcomes of the MINIject drainage system for uncontrolled glaucoma from the STAR-I first-in-human trial”, British Journal of Ophthalmology Published Online First: 03 October 2020. doi: 10.1136/bjophthalmol-2020-316888; in press (Open Access)

• García Feijoó J, Denis P, Hirneiß C, Aptel F, Perucho L, Hussain Z, Lorenz K, Pfeiffer N, on behalf of the STAR-II investigators. “A European Study of the Performance and Safety of MINIject in Patients with Medically Uncontrolled Open-Angle Glaucoma (STAR-II)”, Journal of Glaucoma. 2020 Oct; 29(10):864-871 (Open Access)

• Grierson I, Minckler D, Rippy M.K., Marshall A.J., Collignon N, Bianco J, Detry B, Murray J.A. “A novel suprachoroidal microinvasive glaucoma implant: in vivo biocompatibility and biointegration”, BMC Biomed Eng 2, 10 (2020) (Open Access)

• Denis P, Hirneiß C, Reddy KP, Kamarthy A, Calvo E, Hussain Z, Ahmed IIK. “A First-in-Human Study of the Efficacy and Safety of MINIject in Patients with Medically Uncontrolled Open-Angle Glaucoma (STAR-I)”, Ophthalmology Glaucoma. 2019; 2(5):290-297 (Open Access)

• König S, Hirneiß CW. “STARflo-a suprachoroidal drainage implant in glaucoma surgery”, Ophthalmologe. 2018 Aug;115(8):670-675

• Fili S, Wölfelschneider P, Kohlhaas M. “The STARflo glaucoma implant: preliminary 12 months results”, Graefes Arch Clin Exp Ophthalmol. 2018 Apr;256(4):773-781

• Vinod K. “Suprachoroidal shunts”, Curr Opin Ophthalmol. 2018 Mar;29(2):155-161

• Figus M, Posarelli C, Passani A, Albert TG, Oddone F, Sframeli AT, Nardi M. “The supraciliary space as a suitable pathway for glaucoma surgery: Ho-hum or home run?”, Surv Ophthalmol. 2017 Nov – Dec;62(6):828-837

• Gigon A, Shaarawy T, “The Suprachoroidal Route in Glaucoma Surgery”, J Curr Glaucoma Pract 2016;10(1):13-20.

• Cseke I, Vámosi P, Bausz M, “Starflo glaucoma implant: early experience in Hungary”, Romanian Journal of Ophthalmology, Volume 60, Issue 1, January-March 2016. pp:14-17

• Hovanesian J.A, “Three reasons why MIGS in the suprachoroidal space has a bright future”, MedBlog Nov 2015

• Kammer J.A, Mundy K.M, “Suprachoroidal Devices in Glaucoma Surgery”, Middle East Afr J Ophthalmol. 2015 Jan-Mar; 22(1): 45–52. doi: 10.4103/0974-9233.148348

• Pourjavan S, Collignon N, De Groot V, “STARflo Glaucoma Implant 12 month clinical results”, Acta Ophth, Volume 91, Issue s252, August 2013. DOI: 10.1111/j.1755-3768.2013.3723.x

• Fleckman P, UsuiM, Zhao G, et al. “Cutaneous and inflammatory response to long-term percutaneous implants of sphere-templated porous/solid poly(HEMA) and silicone in Mice”, J Biomed Mater Res A. 2012 May; 100(5): 1256–1268. doi:10.1002/jbm.a.34012

• “Surgical Innovations in Glaucoma”, Editors: Samples, John R., Ahmed, Iqbal Ike K. (Eds.), Section 22 : STARflo – Pourjavan S, Collignon N.J.M., De Groot V, et al. – Pages 235-251. ISBN 978-1-4614-8348-9